Heterozygous CX3CR1 deficiency in microglia restores neuronal β-amyloid clearance pathways and slows progression of Alzheimer's like-disease in PS1-APP mice

SE Hickman, EK Allison, U Coleman… - Frontiers in …, 2019 - frontiersin.org
CX3CR1 is a chemokine receptor expressed on microglia that binds Fractalkine (CX3CL1)
and regulates microglial recruitment to sites of neuroinflammation. Full deletion of CX3CR1 …

[HTML][HTML] CX3CR1 deficiency alters microglial activation and reduces beta-amyloid deposition in two Alzheimer's disease mouse models

S Lee, NH Varvel, ME Konerth, G Xu… - The American journal of …, 2010 - Elsevier
Microglia, the primary immune effector cells in the brain, continually monitor the tissue
parenchyma for pathological alterations and become activated in Alzheimer's disease. Loss …

CXCR3 promotes plaque formation and behavioral deficits in an Alzheimer's disease model

M Krauthausen, MP Kummer… - The Journal of …, 2015 - Am Soc Clin Investig
Chemokines are important modulators of neuroinflammation and neurodegeneration. In the
brains of Alzheimer's disease (AD) patients and in AD animal models, the chemokine …

CX3CR1 in microglia regulates brain amyloid deposition through selective protofibrillar amyloid-β phagocytosis

Z Liu, C Condello, A Schain, R Harb… - Journal of …, 2010 - Soc Neuroscience
In Alzheimer's disease (AD), amyloid-β (Aβ) deposits are frequently surrounded by activated
microglia but the precise role of these cells in disease progression remains unclear. The …

CX3CR1 deficiency aggravates amyloid driven neuronal pathology and cognitive decline in Alzheimer's disease

SS Puntambekar, M Moutinho, PBC Lin… - Molecular …, 2022 - Springer
Background Despite its identification as a key checkpoint regulator of microglial activation in
Alzheimer's disease, the overarching role of CX3CR1 signaling in modulating mechanisms …

Opposing effects of membrane-anchored CX3CL1 on amyloid and tau pathologies via the p38 MAPK pathway

S Lee, G Xu, TR Jay, S Bhatta, KW Kim… - Journal of …, 2014 - Soc Neuroscience
Several Alzheimer's disease (AD) risk genes are specifically expressed by microglia within
the CNS. However, the mechanisms by which microglia regulate the pathological hallmarks …

CX3CR1 protein signaling modulates microglial activation and protects against plaque-independent cognitive deficits in a mouse model of Alzheimer disease

SH Cho, B Sun, Y Zhou, TM Kauppinen… - Journal of Biological …, 2011 - ASBMB
Aberrant microglial activation has been proposed to contribute to the cognitive decline in
Alzheimer disease (AD), but the underlying molecular mechanisms remain enigmatic …

Effects of cx3cr1 and fractalkine chemokines in amyloid beta clearance and p-tau accumulation in Alzheimer, s disease (ad) rodent models: is fractalkine a systemic …

JJ Merino, V Muñetón-Gómez… - Current Alzheimer …, 2016 - ingentaconnect.com
Microglia and astrocytes are the major source of cytokines in Alzheimer, s disease (AD).
CX3CR1 is a delta chemokine receptor found in microglia and its neuronal ligand …

CC chemokine receptor 2 deficiency aggravates cognitive impairments and amyloid pathology in a transgenic mouse model of Alzheimer's disease

G Naert, S Rivest - Journal of Neuroscience, 2011 - Soc Neuroscience
Circulating monocytoid cells have the ability to infiltrate nervous tissue, differentiate into
microglia, and clear amyloid-β (Aβ) from the brain of mouse models of Alzheimer's disease …

Cx3cr1-deficient microglia exhibit a premature aging transcriptome

S Gyoneva, R Hosur, D Gosselin… - Life science …, 2019 - life-science-alliance.org
CX3CR1, one of the highest expressed genes in microglia in mice and humans, is
implicated in numerous microglial functions. However, the molecular mechanisms …